FierceBiotech21h
Gilead roars into JPM25, inking $1.7B inflammation deal with Leo Pharma
Gilead continues its divergence out of its original infectious disease beginnings and into cancer and now, more deeply than ...
Gilead, LEO Pharma Enter Strategic Partnership To Accelerate Development Of Oral STAT6 Program
Gilead Sciences, Inc. (GILD) and LEO Pharma entered strategic partnership to develop and commercialize LEO Pharma's small molecule ...
Gilead, LEO Pharma partner to develop programs for inflammatory diseases
Gilead Sciences said on Saturday that it entered into a partnership with Denmark's LEO Pharma to develop programs to treat ...
Business Wire1d
Gilead and LEO Pharma Enter Into Strategic Partnership to Accelerate Development of Oral STAT6 Program With Potential in Multiple Inflammatory Diseases
Gilead Sciences, Inc. (Nasdaq: GILD) and LEO Pharma today announced a strategic partnership to accelerate the development and commercialization of LEO ...
Gilead in pact for anti-inflammatory drugs in a deal worth up to $1.7B
Gilead Sciences (GILD) partners with LEO Pharma in a $1.7B agreement to develop anti-inflammatory drugs. Read more here.
Bernstein Sticks to Its Buy Rating for Gilead Sciences (GILD)
In a report released yesterday, Courtney Breen from Bernstein maintained a Buy rating on Gilead Sciences (GILD – Research Report), with a price ...
Le Lézard3d
New and Late-Model Tractor Trucks and Trailers Hit the Block in Jan. 16 Bankruptcy Sale
A Tiger Group live webcast auction on Jan. 16 will feature more than 50 new and late-model trucking assets?both tractor trucks from well-known makers such as International, Peterbilt, Freightliner, ...
Le Lézard4d
Multiple Viral Threats Amplify Call for Preparedness with Broad-Spectrum Antivirals
Dr. Anil Diwan, President of NanoViricides, Inc. (the "Company"), comments on the many viruses that could cause pandemics that are going around already.This season, two different genotypes of H5N1 ...